MX362271B - Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso. - Google Patents

Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso.

Info

Publication number
MX362271B
MX362271B MX2013013855A MX2013013855A MX362271B MX 362271 B MX362271 B MX 362271B MX 2013013855 A MX2013013855 A MX 2013013855A MX 2013013855 A MX2013013855 A MX 2013013855A MX 362271 B MX362271 B MX 362271B
Authority
MX
Mexico
Prior art keywords
methods
cyclosporine
preparation
crystalline form
crystalline forms
Prior art date
Application number
MX2013013855A
Other languages
English (en)
Other versions
MX2013013855A (es
Inventor
Karami Kiomars
s graham Richard
V Gore Anuradha
W Smith Scott
Wu Ke
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46178866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX362271(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2013013855A publication Critical patent/MX2013013855A/es
Publication of MX362271B publication Critical patent/MX362271B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona generalmente con formas cristalinas de ciclosporina A y particularmente con una forma nueva identificada de ciclosporina A. la invención se relaciona con métodos para su preparación y métodos para tratar algunos trastornos aculares.
MX2013013855A 2011-05-27 2012-05-25 Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso. MX362271B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161490887P 2011-05-27 2011-05-27
PCT/US2012/039611 WO2012166610A1 (en) 2011-05-27 2012-05-25 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof

Publications (2)

Publication Number Publication Date
MX2013013855A MX2013013855A (es) 2014-02-17
MX362271B true MX362271B (es) 2019-01-10

Family

ID=46178866

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013855A MX362271B (es) 2011-05-27 2012-05-25 Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso.

Country Status (19)

Country Link
US (4) US8772245B2 (es)
EP (2) EP3521302A1 (es)
JP (1) JP6163482B2 (es)
KR (1) KR102079402B1 (es)
CN (1) CN103649108B (es)
AR (1) AR086586A1 (es)
AU (4) AU2012262513B2 (es)
BR (1) BR112013030554B1 (es)
CA (1) CA2836946C (es)
CL (1) CL2013003400A1 (es)
IL (2) IL229475A0 (es)
MX (1) MX362271B (es)
MY (1) MY180581A (es)
RU (1) RU2602062C2 (es)
SG (1) SG10201607344UA (es)
TW (1) TWI554522B (es)
UA (1) UA113627C2 (es)
WO (1) WO2012166610A1 (es)
ZA (1) ZA201308665B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080442B (zh) 2011-11-15 2018-01-05 阿勒根公司 环孢菌素a形式2的悬浮液
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
EP2780358B1 (en) 2011-11-15 2016-03-23 Allergan, Inc. Cyclosporine a form 2 and method of making same
RU2639393C2 (ru) * 2011-11-15 2017-12-21 Аллерган, Инк. Состав пролонгированного действия циклоспорина формы 2
CA2874548A1 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
US10524661B2 (en) * 2013-06-12 2020-01-07 Proactive Live, Inc. Sleep monitoring and stimulation
KR20170030093A (ko) 2014-07-18 2017-03-16 알레간 인코포레이티드 결막하 및 눈주위 주사를 위한 사이클로스포린 a의 현탁액 조성물
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
US10443292B2 (en) * 2016-04-25 2019-10-15 Magna Closures, Inc. Non-contact obstacle detection system for motor vehicles
EP3643723B1 (en) * 2017-05-17 2024-05-15 Yuyu Pharma, Inc. Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
EP4387589A4 (en) * 2021-08-20 2025-09-03 Sun Pharmaceutical Ind Ltd STABLE OPHTHALMIC FORMULATION OF CYCLOSPORINE AND PROCESS FOR ITS MANUFACTURE
TW202430537A (zh) 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法
CN120731215A (zh) 2023-03-20 2025-09-30 中外制药株式会社 用于产生环肽的共晶的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
BRPI0811538A2 (pt) 2007-05-04 2015-08-11 Allergan Inc Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares.
US20090286718A1 (en) * 2008-01-04 2009-11-19 Sirion Therapeutics, Inc. Stable Aqueous Cyclosporin Compositions

Also Published As

Publication number Publication date
KR102079402B1 (ko) 2020-02-19
AU2019204192B2 (en) 2021-02-04
AU2012262513A1 (en) 2013-12-12
US20140315827A1 (en) 2014-10-23
BR112013030554A2 (pt) 2016-09-06
ZA201308665B (en) 2014-07-30
KR20140047054A (ko) 2014-04-21
IL290158A (en) 2022-03-01
JP2014515372A (ja) 2014-06-30
RU2013155033A (ru) 2015-07-20
US20160083432A1 (en) 2016-03-24
AU2012262513B2 (en) 2016-03-17
EP2714720A1 (en) 2014-04-09
CN103649108B (zh) 2017-03-29
WO2012166610A1 (en) 2012-12-06
TWI554522B (zh) 2016-10-21
CN103649108A (zh) 2014-03-19
US20210269484A1 (en) 2021-09-02
UA113627C2 (xx) 2017-02-27
TW201311730A (zh) 2013-03-16
CA2836946C (en) 2017-08-01
EP3521302A1 (en) 2019-08-07
NZ719272A (en) 2017-10-27
AU2019204192A1 (en) 2019-07-04
AU2017265008A1 (en) 2017-12-07
MX2013013855A (es) 2014-02-17
JP6163482B2 (ja) 2017-07-12
BR112013030554B1 (pt) 2020-12-15
US20130023482A1 (en) 2013-01-24
CL2013003400A1 (es) 2014-08-18
IL229475A0 (en) 2014-01-30
CA2836946A1 (en) 2012-12-06
US8772245B2 (en) 2014-07-08
SG10201607344UA (en) 2016-10-28
RU2602062C2 (ru) 2016-11-10
NZ618213A (en) 2016-05-27
US9206228B2 (en) 2015-12-08
EP2714720B1 (en) 2018-12-26
AR086586A1 (es) 2014-01-08
AU2016203990A1 (en) 2016-06-30
MY180581A (en) 2020-12-02

Similar Documents

Publication Publication Date Title
MX362271B (es) Nueva forma cristalina de ciclosporina a, metodos de preparacion y metodos para su uso.
IL274469A (en) Compositions, uses and methods for the treatment of metabolic disorders and diseases
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
PH12014500904B1 (en) Antibody formulations and methods
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
WO2013177133A3 (en) Generation of human ips cells by a synthetic self- replicative rna
MX2019011905A (es) Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica.
ZA201306471B (en) Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines,compositions thereof,and methods of treatment therewith
EP2665696A4 (en) PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOR-2-PROPENE
WO2012106393A3 (en) Withanolide isolated from physalis longifolia and analogs and methods of use thereof
SG10202010665YA (en) Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
WO2012129341A3 (en) Disease detection in plants
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
WO2013034979A3 (en) Crystalline forms of cabazitaxel
IL232710A0 (en) l-serine preparations, methods and uses for the treatment of neurodegenerative diseases and disorders
ZA201403430B (en) 4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
UA108878C2 (ru) Ингибиторы протеинтирозинкиназной активности
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2013007567A (es) Procedimiento para preparar poliestereteroles.
IN2014DN06964A (es)
MX2013015347A (es) Terapia direccionada al receptor del factor de crecimiento epidermico (egfr).
HK1201067A1 (en) Sialic acid analogs
WO2013155465A8 (en) Substituted xanthine derivatives

Legal Events

Date Code Title Description
FG Grant or registration